Inventor · Midlothian, TX, US

Sandra Zurawski

38Patents
10h-index
29Co-inventors
75Inventor score

Filing activity: Sep 4, 1986 → Jun 6, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US5696234A Muteins of mammalian cytokine interleukin-13 Human Necessities 42 Expired
US9102734B2 Fusion proteins comprising antibody and HPV E6 and E7 antigens Emerging Cross-Sectional Technologies 39 Active
US8449888B2 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Chemistry; Metallurgy 34 Active
US8236934B2 Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) Chemistry; Metallurgy 32 Active
US8728481B2 Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) Chemistry; Metallurgy 30 Active
US8057798B2 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Chemistry; Metallurgy 28 Active
US9102730B2 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Chemistry; Metallurgy 25 Active
US8586052B2 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Chemistry; Metallurgy 25 Active
US9234040B2 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Chemistry; Metallurgy 25 Active
US9109011B2 Dendritic cell-specific antibody conjugate comprising anti-CD40 monoclonal antibodies conjugated to HIV-1 Gag/Nef Chemistry; Metallurgy 13 Active
US6479638B1 Antibodies that specifically bind DNAX leukocyte associated immunoglobulin-like receptor Chemistry; Metallurgy 10 Expired
US5017692A Truncated human interleukin-a alpha Chemistry; Metallurgy 10 Expired
US8481314B2 Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1) Emerging Cross-Sectional Technologies 9 Active
US9339556B2 Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1) Emerging Cross-Sectional Technologies 9 Active
US9562104B2 Anti-CD40 antibodies Emerging Cross-Sectional Technologies 5 Active
US9315580B2 Vaccines directed to langerhans cells Chemistry; Metallurgy 5 Active
US6676939B2 Methods of modulating IL-174 response Emerging Cross-Sectional Technologies 2 Expired
US10286058B2 Vaccines against HPV and HPV-related diseases Chemistry; Metallurgy 2 Active
US7999078B2 Antibodies that bind DNAX leukocyte associated immunoglobulin-like receptor Emerging Cross-Sectional Technologies 2 Active
US9567401B2 Anti-CD40 antibodies Emerging Cross-Sectional Technologies 1 Active
US5136022A T cell activation markers Chemistry; Metallurgy 1 Expired
US10683361B2 Anti-CD40 antibodies Emerging Cross-Sectional Technologies 1 Active
US10087256B2 Method of making an anti-CD40 antibody Emerging Cross-Sectional Technologies 1 Active
US10610585B2 Methods and compositions for treating and preventing HIV Chemistry; Metallurgy 0 Active
US12214034B2 Vaccines against HPV and HPV-related diseases Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.